Alpha 2.0
Login Register
» Authors » Sandrine Leroy

Sandrine Leroy

Explore the profile of Sandrine Leroy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 1017
Followers 0
Related Specialties
Pediatrics
General Medicine
Infectious Diseases
Top 10 Co-Authors
Martin Chalumeau
Dominique Gendrel
Gerard Breart
Albert Bensman
Luc Quintin
Alain Gervaix
Tim Ulinski
Eric Delaporte
Fabrice Petitjeans
Annick Galetto-Lacour
Published In
Pediatr Nephrol
PLoS One
Pediatrics
J Pediatr
J Urol
Affiliations
Soon will be listed here.
Recent Articles
1.
Improved understanding of the respiratory drive pathophysiology could lead to earlier spontaneous breathing in severe acute respiratory distress syndrome
Petitjeans F, Leroy S, Pichot C, Ghignone M, Quintin L, Longrois D, et al.
Eur J Anaesthesiol Intensive Care . 2025 Feb; 2(5):e0030. PMID: 39916810
Glossary: Glossary and Abbreviations_SDC.
2.
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)
McLaughlin V, Channick R, Kim N, Frantz R, McConnell J, Melendres-Groves L, et al.
Pulm Circ . 2022 Nov; 12(4):e12150. PMID: 36381290
Macitentan is an oral endothelin receptor antagonist for the management of pulmonary arterial hypertension (PAH). The OPsumit® USers Registry (OPUS) and the OPsumit® Historical USers cohort (OrPHeUS) medical chart review...
3.
Is the Sympathetic System Detrimental in the Setting of Septic Shock, with Antihypertensive Agents as a Counterintuitive Approach? A Clinical Proposition
Petitjeans F, Geloen A, Pichot C, Leroy S, Ghignone M, Quintin L
J Clin Med . 2021 Oct; 10(19). PMID: 34640590
Mortality in the setting of septic shock varies between 20% and 100%. Refractory septic shock leads to early circulatory failure and carries the worst prognosis. The pathophysiology is poorly understood...
4.
Does Interrupting Self-Induced Lung Injury and Respiratory Drive Expedite Early Spontaneous Breathing in the Setting of Early Severe Diffuse Acute Respiratory Distress Syndrome?
Petitjeans F, Leroy S, Pichot C, Ghignone M, Quintin L, Constantin J
Crit Care Med . 2021 Aug; 50(8):1272-1276. PMID: 34369430
No abstract available.
5.
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon
Calmy A, Tovar Sanchez T, Kouanfack C, Mpoudi-Etame M, Leroy S, Perrineau S, et al.
Lancet HIV . 2020 Oct; 7(10):e677-e687. PMID: 33010241
Background: Updated WHO guidelines recommend a dolutegravir-based regimen as the preferred first-line treatment for HIV infection and low-dose efavirenz (400 mg) as an alternative. We aimed to report the non-inferior...
6.
A Centrally Acting Antihypertensive, Clonidine, Sedates Patients Presenting With Acute Respiratory Distress Syndrome Evoked by Severe Acute Respiratory Syndrome-Coronavirus 2
Petitjeans F, Martinez J, des Deserts M, Leroy S, Quintin L, Escarment J
Crit Care Med . 2020 Jul; 48(10):e991-e993. PMID: 32618691
No abstract available.
7.
Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1
Kouanfack C, Mpoudi-Etame M, Omgba Bassega P, Eymard-Duvernay S, Leroy S, Boyer S, et al.
N Engl J Med . 2019 Jul; 381(9):816-826. PMID: 31339676
Background: An efavirenz-based regimen (with a 600-mg dose of efavirenz, known as EFV600) was the World Health Organization preferred first-line treatment for human immunodeficiency virus type 1 (HIV-1) infection until...
8.
On the Right Track, Finally?
Petitjeans F, Leroy S, Geloen A, Pichot C, Ghignone M, Quintin L
Crit Care Med . 2019 Apr; 47(5):e431-e432. PMID: 30985467
No abstract available.
9.
Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study
Diallo M, Rabilloud M, Ayouba A, Toure A, Thaurignac G, Keita A, et al.
Lancet Infect Dis . 2019 Feb; 19(3):308-316. PMID: 30765243
Background: The prevalence of Ebola virus infection among people who have been in contact with patients with Ebola virus disease remains unclear, but is essential to understand the dynamics of...
10.
Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry
Doobaree I, Newland A, McDonald V, Nandigam R, Mensah L, Leroy S, et al.
Eur J Haematol . 2019 Feb; 102(5):416-423. PMID: 30758874
Background: Romiplostim is a thrombopoietin-mimetic peptibody for adult refractory chronic immune thrombocytopenia (ITP). We aimed to describe ITP patients receiving romiplostim, platelet counts and romiplostim usage in UK clinical practice....